Class information for:
Level 1: DIMETHYL FUMARATE//FUMARIC ACID ESTERS//MONOMETHYL FUMARATE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
22994 362 34.7 76%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
188 3       DERMATOLOGY//CONTACT DERMATITIS//PSORIASIS 55369
551 2             PSORIASIS//PSORIATIC ARTHRITIS//DERMATOLOGY 14610
22994 1                   DIMETHYL FUMARATE//FUMARIC ACID ESTERS//MONOMETHYL FUMARATE 362

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DIMETHYL FUMARATE authKW 4983130 27% 62% 96
2 FUMARIC ACID ESTERS authKW 2815561 12% 76% 44
3 MONOMETHYL FUMARATE authKW 1323939 5% 83% 19
4 BG 12 authKW 567018 3% 61% 11
5 FUMARATES authKW 385598 2% 57% 8
6 ANTI MOULD AGENT authKW 253053 1% 100% 3
7 DELAYED RELEASE DIMETHYL FUMARATE authKW 234304 1% 56% 5
8 FUMADERM authKW 168702 1% 100% 2
9 HYDROXYCARBOXYLIC ACID RECEPTOR 2 authKW 168702 1% 100% 2
10 SOFA DERMATITIS authKW 168702 1% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Dermatology 7341 34% 0% 124
2 Clinical Neurology 179 11% 0% 40
3 Pharmacology & Pharmacy 156 14% 0% 52
4 Allergy 134 3% 0% 11
5 Neurosciences 128 13% 0% 48
6 Immunology 55 8% 0% 28
7 Chemistry, Medicinal 16 3% 0% 10
8 Multidisciplinary Sciences 16 1% 0% 5
9 Medicine, General & Internal 7 4% 0% 14
10 Rheumatology 7 1% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNIV CLIN BOCHUM 168702 1% 100% 2
2 BIOMED PNEUMOL 112467 1% 67% 2
3 PSORIASIS 110971 3% 13% 10
4 MULTIPLE SCLEROSIS PROGRAM 105099 2% 14% 9
5 ABT DERMATOL VENEROL ALLEGOL KLINIKUM 84351 0% 100% 1
6 ABT NEUROIMMUNOL NEUROONKOL 84351 0% 100% 1
7 BIOANAL IMMUNOGENEC BIOMARKERS 84351 0% 100% 1
8 DEP NEUROL CLIN NEUROIMMUNOL NEUROCHEM 84351 0% 100% 1
9 DERMATOL ALLERGYHUS 84351 0% 100% 1
10 DERMATONEVEROL 84351 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 7565 2% 1% 9
2 BRITISH JOURNAL OF DERMATOLOGY 5988 8% 0% 28
3 DERMATITIS 2792 1% 1% 4
4 ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 2459 1% 1% 3
5 THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 2201 1% 1% 2
6 MULTIPLE SCLEROSIS JOURNAL 1755 2% 0% 7
7 DERMATOLOGY 1684 2% 0% 9
8 JOURNAL OF NEUROINFLAMMATION 1251 1% 0% 5
9 SKIN PHARMACOLOGY 1176 1% 1% 2
10 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 1176 1% 1% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 DIMETHYL FUMARATE 4983130 27% 62% 96 Search DIMETHYL+FUMARATE Search DIMETHYL+FUMARATE
2 FUMARIC ACID ESTERS 2815561 12% 76% 44 Search FUMARIC+ACID+ESTERS Search FUMARIC+ACID+ESTERS
3 MONOMETHYL FUMARATE 1323939 5% 83% 19 Search MONOMETHYL+FUMARATE Search MONOMETHYL+FUMARATE
4 BG 12 567018 3% 61% 11 Search BG+12 Search BG+12
5 FUMARATES 385598 2% 57% 8 Search FUMARATES Search FUMARATES
6 ANTI MOULD AGENT 253053 1% 100% 3 Search ANTI+MOULD+AGENT Search ANTI+MOULD+AGENT
7 DELAYED RELEASE DIMETHYL FUMARATE 234304 1% 56% 5 Search DELAYED+RELEASE+DIMETHYL+FUMARATE Search DELAYED+RELEASE+DIMETHYL+FUMARATE
8 FUMADERM 168702 1% 100% 2 Search FUMADERM Search FUMADERM
9 HYDROXYCARBOXYLIC ACID RECEPTOR 2 168702 1% 100% 2 Search HYDROXYCARBOXYLIC+ACID+RECEPTOR+2 Search HYDROXYCARBOXYLIC+ACID+RECEPTOR+2
10 SOFA DERMATITIS 168702 1% 100% 2 Search SOFA+DERMATITIS Search SOFA+DERMATITIS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BALAK, DMW , ARANI, SF , HAJDARBEGOVIC, E , HAGEMANS, CAF , BRAMER, WM , THIO, HB , NEUMANN, HAM , (2016) EFFICACY, EFFECTIVENESS AND SAFETY OF FUMARIC ACID ESTERS IN THE TREATMENT OF PSORIASIS: A SYSTEMATIC REVIEW OF RANDOMIZED AND OBSERVATIONAL STUDIES.BRITISH JOURNAL OF DERMATOLOGY. VOL. 175. ISSUE 2. P. 250 -262 54 76% 0
2 GILLARD, GO , COLLETTE, B , ANDERSON, J , CHAO, JH , SCANNEVIN, RH , HUSS, DJ , FONTENOT, JD , (2015) DMF, BUT NOT OTHER FUMARATES, INHIBITS NF-KAPPA B ACTIVITY IN VITRO IN AN NRF2-INDEPENDENT MANNER.JOURNAL OF NEUROIMMUNOLOGY. VOL. 283. ISSUE . P. 74 -85 41 60% 17
3 AL-JADERI, Z , MAGHAZACHI, AA , (2016) UTILIZATION OF DIMETHYL FUMARATE AND RELATED MOLECULES FOR TREATMENT OF MULTIPLE SCLEROSIS, CANCER, AND OTHER DISEASES.FRONTIERS IN IMMUNOLOGY. VOL. 7. ISSUE . P. - 47 64% 0
4 DEEKS, ED , (2016) DIMETHYL FUMARATE: A REVIEW IN RELAPSING-REMITTING MS.DRUGS. VOL. 76. ISSUE 2. P. 243 -254 32 73% 3
5 BOMPREZZI, R , (2015) DIMETHYL FUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: AN OVERVIEW.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. VOL. 8. ISSUE 1. P. 20 -30 27 73% 28
6 LIJNEN, R , OTTERS, E , BALAK, D , THIO, B , (2016) LONG-TERM SAFETY AND EFFECTIVENESS OF HIGH-DOSE DIMETHYLFUMARATE IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS: A PROSPECTIVE SINGLE-BLINDED FOLLOW-UP STUDY.JOURNAL OF DERMATOLOGICAL TREATMENT. VOL. 27. ISSUE 1. P. 31 -36 25 83% 3
7 LINKER, RA , GOLD, R , (2013) DIMETHYL FUMARATE FOR TREATMENT OF MULTIPLE SCLEROSIS: MECHANISM OF ACTION, EFFECTIVENESS, AND SIDE EFFECTS.CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. VOL. 13. ISSUE 11. P. - 31 74% 23
8 GOLD, R , LINKER, RA , STANGEL, M , (2012) FUMARIC ACID AND ITS ESTERS: AN EMERGING TREATMENT FOR MULTIPLE SCLEROSIS WITH ANTIOXIDATIVE MECHANISM OF ACTION.CLINICAL IMMUNOLOGY. VOL. 142. ISSUE 1. P. 44-48 25 89% 43
9 MOHARREGH-KHIABANI, D , LINKER, RA , GOLD, R , STANGEL, M , (2009) FUMARIC ACID AND ITS ESTERS: AN EMERGING TREATMENT FOR MULTIPLE SCLEROSIS.CURRENT NEUROPHARMACOLOGY. VOL. 7. ISSUE 1. P. 60-64 25 96% 53
10 MEISSNER, M , VALESKY, EM , KIPPENBERGER, S , KAUFMANN, R , (2012) DIMETHYL FUMARATE - ONLY AN ANTI-PSORIATIC MEDICATION?.JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. VOL. 10. ISSUE 11. P. 793 -802 34 67% 27

Classes with closest relation at Level 1


Rank Class id link
1 22413 ALEMTUZUMAB//DACLIZUMAB//MS CLIN CENT TEXAS
2 2611 PSORIASIS//EFALIZUMAB//USTEKINUMAB
3 1131 INTERFERON BETA//MULTIPLE SCLEROSIS//GLATIRAMER ACETATE
4 1613 NRF2//KEAP1//ANTIOXIDANT RESPONSE ELEMENT
5 22033 CHILDHOOD PSORIASIS//ACRODERMATITIS CONTINUA OF HALLOPEAU//PERIANAL STREPTOCOCCAL DERMATITIS
6 14241 MULTIPLE SCLEROSIS//NEUROREHABIL WARD//NIRU
7 26412 LINOMIDE//LAQUINIMOD//TASQUINIMOD
8 12751 NIACIN//LAROPIPRANT//GPR109A
9 29066 INTERMEDIATE VOLTAGE EM//BIOCI ENGN//CELL CALCIUM TMB 8
10 28309 BHUTANESE TRADITIONAL MEDICINE//FUMARIA//MANJONG SORIG PHARMACEUT

Go to start page